Literature DB >> 9203684

Progress toward global polio eradication.

H F Hull1, M E Birmingham, B Melgaard, J W Lee.   

Abstract

Significant progress is being made towards the global eradication of poliomyelitis by the year 2000. The strategies recommended by the World Health Organization for polio eradication are as follows: maintaining high routine immunization coverage; conducting nationwide mass immunization campaigns; building effective, laboratory-based surveillance for acute flaccid paralysis; and conducting localized immunization campaigns directed at the final reservoirs of virus transmission. Sixty-three countries have conducted nationwide anti-polio immunization campaigns. Three hundred million children were immunized in these campaigns worldwide in 1995. The reported incidence of poliomyelitis has fallen by approximately 80% since the global target was set in 1988, and the geographic range of polio is being restricted. The major challenges for achieving eradication are establishing effective surveillance systems in all countries and mobilizing the resources needed to fully implement the recommended strategies in the 67 countries in which polio remains endemic.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203684     DOI: 10.1093/infdis/175.supplement_1.s4

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Enterovirus surveillance of Italian healthy children.

Authors:  A M Patti; A L Santi; L Fiore; L Vellucci; D De Stefano; E Bellelli; S Barbuti; G M Fara
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; A Bobrov; H Rudich; A Vonsover; L Shulman; O Kew; E Mendelson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy.

Authors:  D R Kilpatrick; B Nottay; C F Yang; S J Yang; E Da Silva; S Peñaranda; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization.

Authors:  L De; C F Yang; E Da Silva; J Boshell; P Cáceres; J R Gómez; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

Authors:  O M Kew; R W Sutter; B K Nottay; M J McDonough; D R Prevots; L Quick; M A Pallansch
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Immunization programs in non-traditional settings.

Authors:  Shelagh A Weatherill; Jane A Buxton; Patricia C Daly
Journal:  Can J Public Health       Date:  2004 Mar-Apr

7.  Progress toward polio eradication--Somalia, 1998-2013.

Authors:  Chukwuma Mbaeyi; Raoul Kamadjeu; Abdirahman Mahamud; Jenna Webeck; Derek Ehrhardt; Abraham Mulugeta
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

8.  Conducting public health surveillance in areas of armed conflict and restricted population access: a qualitative case study of polio surveillance in conflict-affected areas of Borno State, Nigeria.

Authors:  Eric Wiesen; Raymond Dankoli; Melton Musa; Jeff Higgins; Joseph Forbi; Jibrin Idris; Ndadilnasiya Waziri; Oladapo Ogunbodede; Kabiru Mohammed; Omotayo Bolu; Gatei WaNganda; Usman Adamu; Eve Pinsker
Journal:  Confl Health       Date:  2022-05-07       Impact factor: 4.554

9.  Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame.

Authors:  Dominika A Kalkowska; Mark A Pallansch; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2020-01-20       Impact factor: 4.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.